Genetically Engineered Human Immunodeficiency Virus Type 1 (HIV-1) Vaccines
作者： Benjamin Rovinski , Michel Klein
DOI: 10.1007/978-1-4899-1450-7_10
关键词:
摘要: The human immunodeficiency virus type 1 (HIV-1) is the etiological agent of acquired syndrome (AIDS) and related disorders (Barre-Sinoussi et al., 1983; Gallo 1984; Popovic 1984). World Health Organization has recently estimated that 8–10 million people worldwide are infected with HIV-1 this number will rise to 40 by year 2000 (Ksparza 1991). Global projections cumulative total cases AIDS patients time in neighbourhood 15–18 million. development an effective, long-lasting vaccine against represents, therefore, a formidable scientific challenge for international research community its efforts control spread epidemic.
springer.com
sci-hub.st 参考文章(233)
F.L. Graham, L. Prevec, Adenovirus-based expression vectors and recombinant vaccines. Vaccines#R##N#New Approaches to Immunological Problems. ,vol. 20, pp. 363- 390 ,(1992) , 10.1016/B978-0-7506-9265-6.50022-1
Lasky La, Current status of the development of an AIDS vaccine. Critical Reviews in Immunology. ,vol. 9, pp. 153- 172 ,(1989)
Bernard Moss, Vaccinia virus vectors. Vaccines#R##N#New Approaches to Immunological Problems. ,vol. 20, pp. 345- 362 ,(1992) , 10.1016/B978-0-7506-9265-6.50021-X
P. Liacopoulos, B. N. Halpern, R. Binaghi, Monique Liacopoulos-Briot, F. Van Neer, Patterns of in vitro sensitization of isolated smooth muscle tissues with precipitating antibody. Immunology. ,vol. 2, pp. 351- ,(1959)
D. Zagury, B. Bizzini, A. Burny, M. C. Defer, V. Boyer, C. Desgranges, A. Lachgar, J. M. Bertho, J. C. Imbert, J.J. Salaun, O. Picard, J. Bernard, B. Polliotti, A. Achour, K. Lanneval, A. Halbreich, J. Frottier, A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. Journal of Acquired Immune Deficiency Syndromes. ,vol. 5, pp. 539- 546 ,(1992)
Letvin Nl, Li J, Sodroski J, Lord Ci, Haseltine W, Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. Journal of Acquired Immune Deficiency Syndromes. ,vol. 5, pp. 639- 646 ,(1992)
C. O. Tacket, D. Sun, C. A. Hebert, D. W. Archibald, Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial. Journal of Acquired Immune Deficiency Syndromes. ,vol. 3, pp. 954- 958 ,(1990)
Wayne C. Koff, Flossie Wong-Staal, Ronald C. Kennedy, AIDS Research Reviews ,(1992)
Ronald W. Ellis, Vaccines : new approaches to immunological problems Butterworth-Heinemann. ,(1992)
Gilbert Jay, Robert C. Gallo, The Human retroviruses Academic Press. ,(1991)